Novozymes EBITDA Margin 2011-2024 | NVZMY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Novozymes (NVZMY) over the last 10 years. The current EBITDA margin for Novozymes as of June 30, 2024 is .
| Novozymes EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-12-31 |
$2.60B |
$0.58B |
22.16% |
| 2023-09-30 |
$2.56B |
$0.58B |
22.65% |
| 2023-06-30 |
$2.50B |
$0.60B |
24.20% |
| 2023-03-31 |
$2.49B |
$0.64B |
25.55% |
| 2022-12-31 |
$2.49B |
$0.65B |
25.99% |
| 2022-09-30 |
$2.45B |
$0.63B |
25.56% |
| 2022-06-30 |
$2.46B |
$0.63B |
25.51% |
| 2022-03-31 |
$2.43B |
$0.63B |
25.90% |
| 2021-12-31 |
$2.38B |
$0.64B |
26.79% |
| 2021-09-30 |
$2.34B |
$0.64B |
27.50% |
| 2021-06-30 |
$2.29B |
$0.61B |
26.70% |
| 2021-03-31 |
$2.20B |
$0.58B |
26.27% |
| 2020-12-31 |
$2.15B |
$0.56B |
26.04% |
| 2020-09-30 |
$2.15B |
$0.59B |
27.65% |
| 2020-06-30 |
$2.16B |
$0.58B |
26.88% |
| 2020-03-31 |
$2.18B |
$0.63B |
28.89% |
| 2019-12-31 |
$2.16B |
$0.61B |
28.07% |
| 2019-09-30 |
$2.17B |
$0.60B |
27.78% |
| 2019-06-30 |
$2.19B |
$0.64B |
29.13% |
| 2019-03-31 |
$2.23B |
$0.61B |
27.46% |
| 2018-12-31 |
$2.28B |
$0.64B |
28.25% |
| 2018-09-30 |
$2.29B |
$0.64B |
28.07% |
| 2018-06-30 |
$2.29B |
$0.65B |
28.35% |
| 2018-03-31 |
$2.25B |
$0.64B |
28.33% |
| 2017-12-31 |
$2.21B |
$0.62B |
27.87% |
| 2017-09-30 |
$2.16B |
$0.61B |
28.10% |
| 2017-06-30 |
$2.11B |
$0.59B |
27.86% |
| 2017-03-31 |
$2.11B |
$0.59B |
28.08% |
| 2016-12-31 |
$2.10B |
$0.59B |
27.88% |
| 2016-09-30 |
$2.07B |
$0.58B |
28.02% |
| 2016-06-30 |
$2.09B |
$0.59B |
28.04% |
| 2016-03-31 |
$2.08B |
$0.58B |
27.79% |
| 2015-12-31 |
$2.06B |
$0.55B |
26.87% |
| 2015-09-30 |
$2.05B |
$0.51B |
25.06% |
| 2015-06-30 |
$2.06B |
$0.48B |
23.46% |
| 2015-03-31 |
$2.10B |
$0.47B |
22.42% |
| 2014-12-31 |
$2.15B |
$0.53B |
24.63% |
| 2014-09-30 |
$2.19B |
$0.57B |
26.21% |
| 2014-06-30 |
$2.19B |
$0.61B |
27.74% |
| 2014-03-31 |
$2.18B |
$0.62B |
28.52% |
| 2013-12-31 |
$2.12B |
$0.57B |
26.80% |
| 2013-09-30 |
$2.07B |
$0.38B |
18.45% |
| 2013-06-30 |
$2.01B |
$0.34B |
17.16% |
| 2013-03-31 |
$1.93B |
$0.29B |
15.10% |
| 2012-12-31 |
$1.92B |
$0.46B |
23.67% |
| 2012-09-30 |
$1.89B |
$0.10B |
5.49% |
| 2012-06-30 |
$1.93B |
$0.11B |
5.50% |
| 2012-03-31 |
$1.95B |
$0.13B |
6.68% |
| 2011-12-31 |
$1.96B |
$0.34B |
17.44% |
| 2011-09-30 |
$1.93B |
$1.16B |
60.20% |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$32.611B |
$4.149B |
|
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
|
